RSV4

Study Information

Respiratory Syncytial Virus (RSV) is a common, highly contagious virus and may be dangerous for seniors.    RSV can cause long-term damage to the lungs.  RSV is much like the flu or the coronavirus for adults 60 years and older and for those with compromised health conditions. 

Vaccine studies could help.  AMR Lexington is accepting volunteers for an investigational RSV Vaccine clinical research study.

 

Qualified Participants:

  • Are 60 years of age and older
  • Are in otherwise good health
  • Meet other study criteria

If you qualify and participate, you will receive:

  • All study-related medical care at no cost
  • Lab tests
  • Investigational vaccine or placebo

Compensation up to $620.00 is available for time and travel.  Insurance is not required.


If you are interested in participating in this study, please fill out the form below.  We will contact you within 48 hours to follow up and clarify any questions that you, or we, may have.  Per AMR Lexington’s privacy policy, all your personal information that we have obtained will be kept in our secure database, which can only be accessed by authorized AMR Lexington personnel, unless given your permission or except as required by law.

(If a referral, please list the name of the person who referred you.)

By submitting this information, AMR Lexington has my permission to contact me.  My consent allows AMR Lexington to use phone, text, and email messages to contact me.  Message and data rates may apply.  I may contact AMR Lexington at any time to change these preferences. To be removed or to change your contact preferences, please call an AMR Lexington recruitment specialist at 859-264-8999.

×

Make an appointment and we’ll contact you.